OUTCOME AND SAFETY OF RECANALIZATION TREATMENTS IN ISCHEMIC STROKE DUE TO ACUTE BASILAR ARTERY OCCLUSION
RECANALISATION THERAPY IN ISCHEMIC STROKE DUE TO BASILAR ARTERY OCCLUSION IN PEOPLE 115 HOSPITAL, VIETNAM
1 other identifier
observational
150
1 country
1
Brief Summary
Rationale: Recently, two prospective multicenter RCT reported a potential beneficial effect of endovascular thrombectomy (EVT) in patients with an acute symptomatic basilar artery occlusion (BAO). However, the high rate of crossover in BEST study and the long-term of recruitment in BASICS study influenced the validity of the results. Objective: To assess the outcomes and prognostic factors of recanalization therapy in patients with BAO, caused by a CTA/MRA/DSA confirmed occlusion of the basilar artery. Study design: This is a prospective observational study. Study population: Patients with acute ischemic stroke and a confirmed basilar artery occlusion by CTA/MRA/DSA. Main study parameters/outcomes: Favorable outcome at day 90 defined as a modified Rankin Score (mRS - functional scale) of 0-3. The estimate will be adjusted for the known prognostic variables age, time from onset to treatment, stroke severity (NIHSS), PC ASPECT and collateral flow and adjusted and unadjusted estimates with corresponding 95% confidence intervals will be reported.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 26, 2022
CompletedFirst Posted
Study publicly available on registry
June 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJuly 26, 2022
July 1, 2022
2.4 years
May 26, 2022
July 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
favourable outcome
a modified Rankin Score of 0-3
90 (± 14 days) after procedure
Secondary Outcomes (6)
good outcome
90 (± 14 days) after procedure
mortality
90 (± 14 days) after procedure
Dichotomized mRS score
90 (± 14 days) after procedure
Symptomatic intracerebral hemorrhage (sICH)
within 72 hours after procedure
Any intracerebral hemorrhage
within 72 hours after procedure
- +1 more secondary outcomes
Eligibility Criteria
All patients who were acute ischemic stroke due to basilar artery occlusion admitted People 115 Hospital and treated recanalisation therapies : intravenous tPA, bridging tPA and thrombectomy or thrombectomy alone.
You may qualify if:
- Symptoms and signs compatible with ischemia in the basilar artery territory.
- Basilar artery occlusion (BAO) confirmed by CTA or MRA or DSA.
- Age 18 years or older
- Patients were treated with one of these among therapies IVT alone, bridging IVT and thrombectomy or thrombectomy alone..
You may not qualify if:
- Patients did not agree to enroll.
- High-density lesion consistent with hemorrhage of any degree
- Significant cerebellar mass effect or acute hydrocephalus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
People 115 Hospital
Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam
Study Officials
- STUDY DIRECTOR
Huy Thang Nguyen, Professor
People 115 Hospital
Central Study Contacts
Huy Thang Nguyen
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
May 26, 2022
First Posted
June 2, 2022
Study Start
August 1, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
July 26, 2022
Record last verified: 2022-07